B
Bertrand Godeau
Researcher at University of Paris
Publications - 242
Citations - 15942
Bertrand Godeau is an academic researcher from University of Paris. The author has contributed to research in topics: Rituximab & Medicine. The author has an hindex of 58, co-authored 217 publications receiving 13179 citations. Previous affiliations of Bertrand Godeau include French Institute of Health and Medical Research & Paris 12 Val de Marne University.
Papers
More filters
Journal ArticleDOI
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero,Roberto Stasi,Terry Gernsheimer,Marc Michel,Drew Provan,Donald M. Arnold,James B. Bussel,Douglas B. Cines,Beng H. Chong,Nichola Cooper,Bertrand Godeau,Klaus Lechner,Maria Gabriella Mazzucconi,Robert McMillan,Miguel A. Sanz,Paul Imbach,Victor S. Blanchette,Thomas Kühne,Marco Ruggeri,James N. George +19 more
TL;DR: An International Working Group of recognized expert clinicians convened a 2-day structured meeting to define standard terminology and definitions for primary ITP and its different phases and criteria for the grading of severity, and clinically meaningful outcomes and response.
Journal ArticleDOI
International consensus report on the investigation and management of primary immune thrombocytopenia.
Drew Provan,Roberto Stasi,Adrian C. Newland,Victor S. Blanchette,Paula H. B. Bolton-Maggs,James B. Bussel,Beng H. Chong,Douglas B. Cines,Terry Gernsheimer,Bertrand Godeau,John D. Grainger,Ian A. Greer,Beverley J. Hunt,Paul Imbach,Gordon Lyons,Robert McMillan,Francesco Rodeghiero,Miguel A. Sanz,Michael D. Tarantino,Shirley Watson,Joan Young,David J. Kuter +21 more
TL;DR: This consensus document aims to report on new data and provide consensus-based recommendations relating to diagnosis and treatment of ITP in adults, in children, and during pregnancy.
Journal ArticleDOI
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloé Comarmond,Christian Pagnoux,Mehdi Khellaf,Jean-François Cordier,Mohamed Hamidou,Jean-François Viallard,François Maurier,Stéphane Jouneau,Boris Bienvenu,Xavier Puéchal,Olivier Aumaître,Guillaume Le Guenno,Alain Le Quellec,Ramiro Cevallos,Olivier Fain,Bertrand Godeau,Raphaèle Seror,Bertrand Dunogué,Alfred Mahr,Philippe Guilpain,Pascal Cohen,Achille Aouba,Luc Mouthon,Loïc Guillevin +23 more
TL;DR: Although EGPA relapses remain frequent, mortality has declined, at least since 1996, and multivariable analysis identified cardiomyopathy, older age, and diagnosis during or prior to 1996 as independent risk factors for death and lower eosinophil count at diagnosis as predictive of relapse.
Journal ArticleDOI
Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
Benjamin Terrier,Zahir Amoura,Philippe Ravaud,Eric Hachulla,Romain Jouenne,Bernard Combe,Christine Bonnet,Patrice Cacoub,Alain Cantagrel,Michel De Bandt,Olivier Fain,Bruno Fautrel,Philippe Gaudin,Bertrand Godeau,Jean-Robert Harlé,Arnaud Hot,Jean-Emmanuel Kahn,Olivier Lambotte,Claire Larroche,Jean Leone,Olivier Meyer,Béatrice Pallot-Prades,Edouard Pertuiset,Pierre Quartier,Thierry Schaerverbeke,Jean Sibilia,A. Somogyi,Martin Soubrier,Eric Vignon,Brigitte Bader-Meunier,Xavier Mariette,Jacques-Eric Gottenberg +31 more
TL;DR: Data from the AIR registry show a satisfactory tolerance profile and clinical efficacy of RTX in patients with SLE, leaving open the question of the therapeutic use of RTX in SLE.